Found: 15
Select item for more details and to access through your institution.
TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.
- Published in:
- International Immunology, 2007, v. 19, n. 9, p. 1115
- By:
- Publication type:
- Article
Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1825, doi. 10.1007/s00262-010-0908-z
- By:
- Publication type:
- Article
Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1183914
- By:
- Publication type:
- Article
Varicellovirus UL49.5 Proteins Differentially Affect the Function of the Transporter Associated with Antigen Processing, TAP.
- Published in:
- PLoS Pathogens, 2008, v. 4, n. 5, p. 1, doi. 10.1371/journal.ppat.1000080
- By:
- Publication type:
- Article
Natural T-helper immunity against human papillomavirus type 16 (hpv16) e7-derived peptide epitopes in patients with hpv16-positive cervical lesions: Identification of 3 human leukocyte antigen class ii-restricted epitopes.
- Published in:
- International Journal of Cancer, 2001, v. 91, n. 5, p. 612, doi. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1119>3.0.CO;2-C
- By:
- Publication type:
- Article
A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation.
- Published in:
- Nature Communications, 2014, v. 5, n. 5, p. 3832, doi. 10.1038/ncomms4832
- By:
- Publication type:
- Article
Hiding Lipid Presentation: Viral Interference with CD1d-Restricted Invariant Natural Killer T (iNKT) Cell Activation.
- Published in:
- Viruses (1999-4915), 2012, v. 4, n. 10, p. 2379, doi. 10.3390/v4102379
- By:
- Publication type:
- Article
The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 4, p. 1, doi. 10.1371/journal.ppat.1005550
- By:
- Publication type:
- Article
Viral Inhibition of the Transporter Associated with Antigen Processing (TAP): A Striking Example of Functional Convergent Evolution.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 4, p. 1, doi. 10.1371/journal.ppat.1004743
- By:
- Publication type:
- Article
Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling.
- Published in:
- PLoS Pathogens, 2014, v. 10, n. 2, p. 1, doi. 10.1371/journal.ppat.1003960
- By:
- Publication type:
- Article
CD200 Receptor Controls Sex-Specific TLR7 Responses to Viral Infection.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 5, p. 1, doi. 10.1371/journal.ppat.1002710
- By:
- Publication type:
- Article
Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle.
- Published in:
- PLoS Pathogens, 2009, v. 5, n. 6, p. 1, doi. 10.1371/journal.ppat.1000490
- By:
- Publication type:
- Article
The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation.
- Published in:
- PLoS Pathogens, 2009, v. 5, n. 1, p. 1, doi. 10.1371/journal.ppat.1000255
- By:
- Publication type:
- Article
Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.
- Published in:
- Immunology & Cell Biology, 2011, v. 89, n. 3, p. 359, doi. 10.1038/icb.2010.129
- By:
- Publication type:
- Article
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma.
- Published in:
- European Journal of Immunology, 1999, v. 29, n. 4, p. 1292, doi. 10.1002/(SICI)1521-4141(199904)29:04<1292::AID-IMMU1292>3.0.CO;2-6
- By:
- Publication type:
- Article